These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25624918)

  • 1. Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms.
    Jammal MP; DA Silva AA; Filho AM; DE Castro Côbo E; Adad SJ; Murta EF; Nomelini RS
    Oncol Lett; 2015 Feb; 9(2):979-983. PubMed ID: 25624918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines and Prognostic Factors in Epithelial Ovarian Cancer.
    Jammal MP; Martins-Filho A; Silveira TP; Murta EF; Nomelini RS
    Clin Med Insights Oncol; 2016; 10():71-6. PubMed ID: 27512342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.
    Daraï E; Detchev R; Hugol D; Quang NT
    Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.
    Sipak-Szmigiel O; Włodarski P; Ronin-Walknowska E; Niedzielski A; Karakiewicz B; Słuczanowska-Głąbowska S; Laszczyńska M; Malinowski W
    J Ovarian Res; 2017 Apr; 10(1):25. PubMed ID: 28376925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor.
    Yigit R; Massuger LF; Zusterzeel PL; Pots J; Figdor CG; Torensma R
    Int J Gynecol Cancer; 2011 Oct; 21(7):1241-7. PubMed ID: 21946293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
    Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
    Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
    Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
    J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Importance of IL-6, IL-8, and TNF-α in Patients with Ovarian Carcinoma and Benign Cystic Lesions.
    Pawlik W; Pawlik J; Kozłowski M; Łuczkowska K; Kwiatkowski S; Kwiatkowska E; Machaliński B; Cymbaluk-Płoska A
    Diagnostics (Basel); 2021 Sep; 11(9):. PubMed ID: 34573967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
    Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
    Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer.
    Bischof A; Briese V; Richter DU; Bergemann C; Friese K; Jeschke U
    Anticancer Res; 2005; 25(3A):1639-44. PubMed ID: 16033074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium.
    Szlosarek PW; Grimshaw MJ; Kulbe H; Wilson JL; Wilbanks GD; Burke F; Balkwill FR
    Mol Cancer Ther; 2006 Feb; 5(2):382-90. PubMed ID: 16505113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
    Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
    Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines in peritoneal fluid of ovarian neoplasms.
    de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
    J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
    Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
    Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and morphological features of the ovarian brenner tumour: current state of the problem.
    Myroshnychenko MS; Dyadyk OO; Urzhumov VD; Kapustnyk NV; Borzenkova IV; Selivanova LI; Torianyk II; Fedulenkova YY; Kalashnyk IM; Tkachenko PV; Hryhorenko VR; Molodan DV; Myroshnychenko SS
    Wiad Lek; 2020; 73(7):1420-1426. PubMed ID: 32759431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
    Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours.
    Punnonen J; Heinonen PK; Kuoppala T; Jansen CT; Punnonen R
    J Cancer Res Clin Oncol; 1991; 117(6):587-92. PubMed ID: 1744165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Alpha-Smooth Muscle Actin and Fibroblast Activation Protein Alpha in Ovarian Neoplasms.
    da Silva AC; Jammal MP; Etchebehere RM; Murta EFC; Nomelini RS
    Gynecol Obstet Invest; 2018; 83(4):381-387. PubMed ID: 29621774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.